These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An integrated approach to the meta-analysis of genetic association studies using Mendelian randomization. Minelli C; Thompson JR; Tobin MD; Abrams KR Am J Epidemiol; 2004 Sep; 160(5):445-52. PubMed ID: 15321841 [TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of Mendelian randomization studies incorporating all three genotypes. Palmer TM; Thompson JR; Tobin MD Stat Med; 2008 Dec; 27(30):6570-82. PubMed ID: 18767201 [TBL] [Abstract][Full Text] [Related]
4. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Muntjewerff JW; Kahn RS; Blom HJ; den Heijer M Mol Psychiatry; 2006 Feb; 11(2):143-9. PubMed ID: 16172608 [TBL] [Abstract][Full Text] [Related]
5. [Genotype-disease association and possibility to reveal environmentally modifiable disease causes: the use of mendelian randomization principle]. Novotný L; Bencko V Cas Lek Cesk; 2007; 146(4):343-50. PubMed ID: 17491244 [TBL] [Abstract][Full Text] [Related]
6. A unification of multivariate methods for meta-analysis of genetic association studies. Bagos PG Stat Appl Genet Mol Biol; 2008; 7(1):Article31. PubMed ID: 18976227 [TBL] [Abstract][Full Text] [Related]
7. Are homocysteine and MTHFR genotype polymorphism associated with arteriovenous fistula patency? Tai HC; Yang WC; Chen TW; Lin CC Am J Kidney Dis; 2005 Nov; 46(5):993-4; author reply 994. PubMed ID: 16253747 [No Abstract] [Full Text] [Related]
8. 5,10-Methylenetetrahydrofolate reductase polymorphisms and acute lymphoblastic leukemia risk: a meta-analysis. Pereira TV; Rudnicki M; Pereira AC; Pombo-de-Oliveira MS; Franco RF Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1956-63. PubMed ID: 17035405 [TBL] [Abstract][Full Text] [Related]
9. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes. Lin PT; Huang MC; Lee BJ; Cheng CH; Tsai TP; Huang YC Asia Pac J Clin Nutr; 2008; 17(2):330-8. PubMed ID: 18586656 [TBL] [Abstract][Full Text] [Related]
10. Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'. Keavney B; Danesh J; Parish S; Palmer A; Clark S; Youngman L; Delépine M; Lathrop M; Peto R; Collins R Int J Epidemiol; 2006 Aug; 35(4):935-43. PubMed ID: 16870675 [TBL] [Abstract][Full Text] [Related]
11. Polymorphism C776G in the transcobalamin II gene and homocysteine, folate and vitamin B12 concentrations. Association with MTHFR C677T and A1298C and MTRR A66G polymorphisms in healthy children. Aléssio AC; Höehr NF; Siqueira LH; Bydlowski SP; Annichino-Bizzacchi JM Thromb Res; 2007; 119(5):571-7. PubMed ID: 16820193 [TBL] [Abstract][Full Text] [Related]
12. Methylenetetrahydrofolate reductase gene polymorphisms in essential hypertension relation: with the development of hypertensive end-stage renal disease. Tylicki L; Födinger M; Puttinger H; Rutkowski P; Strozecki P; Tyszko S; Rutkowski B; Hörl WH Am J Hypertens; 2005 Nov; 18(11):1442-8. PubMed ID: 16280279 [TBL] [Abstract][Full Text] [Related]
13. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal). Freitas AI; Mendonça I; Guerra G; Brión M; Reis RP; Carracedo A; Brehm A Thromb Res; 2008; 122(5):648-56. PubMed ID: 18384842 [TBL] [Abstract][Full Text] [Related]
14. Using pseudo-data to correct for publication bias in meta-analysis. Bowden J; Thompson JR; Burton P Stat Med; 2006 Nov; 25(22):3798-813. PubMed ID: 16382418 [TBL] [Abstract][Full Text] [Related]
15. Lack of evidence of association between MTHFR C677T polymorphism and congenital heart disease in a TDT study design. Pereira AC; Xavier-Neto J; Mesquita SM; Mota GF; Lopes AA; Krieger JE Int J Cardiol; 2005 Oct; 105(1):15-8. PubMed ID: 16207540 [TBL] [Abstract][Full Text] [Related]
16. Adjusting for bias and unmeasured confounding in Mendelian randomization studies with binary responses. Palmer TM; Thompson JR; Tobin MD; Sheehan NA; Burton PR Int J Epidemiol; 2008 Oct; 37(5):1161-8. PubMed ID: 18463132 [TBL] [Abstract][Full Text] [Related]
17. The choice of a genetic model in the meta-analysis of molecular association studies. Minelli C; Thompson JR; Abrams KR; Thakkinstian A; Attia J Int J Epidemiol; 2005 Dec; 34(6):1319-28. PubMed ID: 16115824 [TBL] [Abstract][Full Text] [Related]
18. Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis. Macis D; Maisonneuve P; Johansson H; Bonanni B; Botteri E; Iodice S; Santillo B; Penco S; Gucciardo G; D'Aiuto G; Rosselli Del Turco M; Amadori M; Costa A; Decensi A Breast Cancer Res Treat; 2007 Dec; 106(2):263-71. PubMed ID: 17260091 [TBL] [Abstract][Full Text] [Related]
19. Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a meta-analysis. Zintzaras E Clin Genet; 2006 Apr; 69(4):327-36. PubMed ID: 16630166 [TBL] [Abstract][Full Text] [Related]
20. Genetic determinants of plasma total homocysteine. Gellekink H; den Heijer M; Heil SG; Blom HJ Semin Vasc Med; 2005 May; 5(2):98-109. PubMed ID: 16047263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]